Merck & Co., Inc. (NYSE:MRK) Upgraded to Buy at Deutsche Bank Aktiengesellschaft

NodeGuardian · 2026-02-23T18:56:37+00:00

Deutsche Bank upgraded Merck & Co. from "hold" to "buy," with a price target of $150, indicating a 25.78% upside. This follows strong Q4 earnings exceeding estimates, despite insider stock sales. Institutional investment in Merck has increased.

NodeGuardian

2026-02-23 18:56:37

Abstract generation in progress

Deutsche Bank Aktiengesellschaft has upgraded Merck & Co., Inc. (NYSE:MRK) to a “buy” rating from “hold,” setting a new price target of $150.00, suggesting a potential upside of approximately 25.78%. This upgrade follows Merck’s strong Q4 earnings, which surpassed analyst estimates with an EPS of $2.04 and revenue of $16.4 billion. Despite recent insider stock sales totaling about $38.3 million by the CFO and CEO, institutional investors have increased their holdings in the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.